Product Images Gabitril
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Gabitril NDC 63459-404 by Cephalon, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
gabitril tiagabine hydrochloride n020646 1
gabitril tiagabine hydrochloride n020646 10
gabitril tiagabine hydrochloride n020646 11
gabitril tiagabine hydrochloride n020646 12
gabitril tiagabine hydrochloride n020646 13
gabitril tiagabine hydrochloride n020646 14
gabitril tiagabine hydrochloride n020646 2
The text describes a chart displaying the reduction in partial seizure rate for patients taking Gabitril at 32 mg/day and 56 mg/day compared to a placebo. The chart shows a significant reduction in seizure rate for the Gabitril group with 50% and 100% reduction seen in some patients. The chart also depicts the percentage of patients that showed improvement, no change, or worsening in their seizure rate.*
gabitril tiagabine hydrochloride n020646 3
This text presents a chart showing the percentage reduction in partial seizure rate for patients taking different doses of GABITRIL, indicated in mg/day. The chart also shows the percentage of patients who experienced improvement, had no change, or experienced worsening of their condition.*
gabitril tiagabine hydrochloride n020646 4
This is a chart showing the percentage reduction in partial seizure rate for patients taking either a placebo or different doses of a medication called Gabitril. The chart also displays the percentage of patients experiencing improvement, no change, or worsening of their seizures.*
gabitril tiagabine hydrochloride n020646 5
This text represents a graph showing the reduction in partial seizure rate for patients taking placebo versus those taking GABITRL 10mg TD. The y-axis shows the percentage of patients, while the x-axis shows the percentage reduction in seizure rate. The graph shows that a higher percentage of patients taking GABITRL experienced improvement in their seizure rate compared to those taking placebo. There is also a category for patients who experienced no change, and another for worsening.*
gabitril tiagabine hydrochloride n020646 6
gabitril tiagabine hydrochloride n020646 7
gabitril tiagabine hydrochloride n020646 8
gabitril tiagabine hydrochloride n020646 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.